Pharmaceutical_industry Head lines
Charles River Labs calls off WuXi Pharmatech buy
(AP)
AP - Charles River Laboratories International Inc., a U.S. medical research equipment and services company, said Friday it is canceling a $1.6 billion acquisition of WuXi PharmaTech after shareholder objections.
Pubished :Fri, 30 Jul 2010 11:07:03 GMT( 15 hours ago )
AP - Charles River Laboratories International Inc., a U.S. medical research equipment and services company, said Friday it is canceling a $1.6 billion acquisition of WuXi PharmaTech after shareholder objections.
Pubished :Fri, 30 Jul 2010 11:07:03 GMT( 15 hours ago )
Sanofi seeks Genzyme fix, Astra gets new drug lift
(Reuters)
Reuters - Hopes for a smart acquisition and a new heart drug overshadowed forecast-beating results from Sanofi-Aventis and AstraZeneca on Thursday, underscoring pressure on both companies to reinvent themselves.
Pubished :Thu, 29 Jul 2010 11:47:09 GMT
Reuters - Hopes for a smart acquisition and a new heart drug overshadowed forecast-beating results from Sanofi-Aventis and AstraZeneca on Thursday, underscoring pressure on both companies to reinvent themselves.
Pubished :Thu, 29 Jul 2010 11:47:09 GMT
AstraZeneca 2Q profit up 22 pct
(AP)
AP - AstraZeneca PLC doubled its share buyback program on Thursday after posting strong second quarter results and revealing that a key new drug — its blood thinner Brilinta — has been given a thumbs up by an advisory committee of the U.S. Food and Drug Administration.
Pubished :Thu, 29 Jul 2010 11:00:40 GMT
AP - AstraZeneca PLC doubled its share buyback program on Thursday after posting strong second quarter results and revealing that a key new drug — its blood thinner Brilinta — has been given a thumbs up by an advisory committee of the U.S. Food and Drug Administration.
Pubished :Thu, 29 Jul 2010 11:00:40 GMT
Bayer's 2nd-quarter profit down 1.3 percent
(AP)
AP - Germany's Bayer AG saw second-quarter net earnings slip by 1.3 percent as a stronger revenue was offset by one-time charges for lawsuits and writing down a cancer drug.
Pubished :Thu, 29 Jul 2010 09:06:40 GMT
AP - Germany's Bayer AG saw second-quarter net earnings slip by 1.3 percent as a stronger revenue was offset by one-time charges for lawsuits and writing down a cancer drug.
Pubished :Thu, 29 Jul 2010 09:06:40 GMT
AstraZeneca doubles buyback as Brilinta shines
(Reuters)
Reuters - AstraZeneca doubled its 2010 share buyback program on Thursday, after posting strong results and winning an endorsement from a U.S. advisory panel for its potential blockbuster heart drug Brilinta.
Pubished :Thu, 29 Jul 2010 08:20:46 GMT
Reuters - AstraZeneca doubled its 2010 share buyback program on Thursday, after posting strong results and winning an endorsement from a U.S. advisory panel for its potential blockbuster heart drug Brilinta.
Pubished :Thu, 29 Jul 2010 08:20:46 GMT
Bayer quarterly earnings fall to 525m euros
(AFP)
AFP - German pharmaceutical giant Bayer said Thursday that its second quarter net profit fell to 525 million euros (680 million dollars), well below market expectations.
Pubished :Thu, 29 Jul 2010 06:24:30 GMT
AFP - German pharmaceutical giant Bayer said Thursday that its second quarter net profit fell to 525 million euros (680 million dollars), well below market expectations.
Pubished :Thu, 29 Jul 2010 06:24:30 GMT
Summary Box: CVS Caremark's PBM deal with Aetna
(AP)
AP - BIG DEAL: CVS Caremark Corp. struck a major 12-year contract with Aetna Inc. to administer Aetna's retail pharmacies and manage purchasing, inventory and prescription filling for Aetna's mail order and specialty businesses.
Pubished :Wed, 28 Jul 2010 18:50:22 GMT
AP - BIG DEAL: CVS Caremark Corp. struck a major 12-year contract with Aetna Inc. to administer Aetna's retail pharmacies and manage purchasing, inventory and prescription filling for Aetna's mail order and specialty businesses.
Pubished :Wed, 28 Jul 2010 18:50:22 GMT
CVS announces deal with Aetna, 2Q profit falls
(AP)
AP - CVS Caremark Corp. Wednesday reported weaker quarterly earnings and lowered its profit forecast, but shares rose as investors approved of a large pharmacy benefit management services contract struck with Aetna.
Pubished :Wed, 28 Jul 2010 18:47:44 GMT
AP - CVS Caremark Corp. Wednesday reported weaker quarterly earnings and lowered its profit forecast, but shares rose as investors approved of a large pharmacy benefit management services contract struck with Aetna.
Pubished :Wed, 28 Jul 2010 18:47:44 GMT
CVS 2Q profit falls, announces deal with Aetna
(AP)
AP - CVS Caremark Corp. said Wednesday it struck a large pharmacy benefit management services contract with health insurer Aetna Inc., but shares fell in premarket trading after the pharmacy chain reported weaker earnings and trimmed its profit forecast.
Pubished :Wed, 28 Jul 2010 12:27:30 GMT
AP - CVS Caremark Corp. said Wednesday it struck a large pharmacy benefit management services contract with health insurer Aetna Inc., but shares fell in premarket trading after the pharmacy chain reported weaker earnings and trimmed its profit forecast.
Pubished :Wed, 28 Jul 2010 12:27:30 GMT
Merck pairs up with Chinese drugmaker Sinopharm
(AP)
AP - Merck & Co. said Tuesday it will team up with Sinopharm, a huge Chinese distributor and maker of pharmaceutical and other health products, to market vaccines and potentially other drugs.
Pubished :Tue, 27 Jul 2010 14:58:01 GMT
AP - Merck & Co. said Tuesday it will team up with Sinopharm, a huge Chinese distributor and maker of pharmaceutical and other health products, to market vaccines and potentially other drugs.
Pubished :Tue, 27 Jul 2010 14:58:01 GMT
Onyx posts positive results for new cancer drug
(AP)
AP - Onyx Pharmaceuticals Inc. on Monday reported positive clinical trial results for its cancer drug candidate, saying it worked for some multiple myeloma patients who have seen other therapies fail.
Pubished :Mon, 26 Jul 2010 16:42:59 GMT
AP - Onyx Pharmaceuticals Inc. on Monday reported positive clinical trial results for its cancer drug candidate, saying it worked for some multiple myeloma patients who have seen other therapies fail.
Pubished :Mon, 26 Jul 2010 16:42:59 GMT
Biogen shares rise on biotech buyout speculation
(AP)
AP - Shares of Biogen Idec Inc. rose Monday on speculation that pharmaceutical companies may start buying up some of the larger biotechnology players.
Pubished :Mon, 26 Jul 2010 17:17:36 GMT
AP - Shares of Biogen Idec Inc. rose Monday on speculation that pharmaceutical companies may start buying up some of the larger biotechnology players.
Pubished :Mon, 26 Jul 2010 17:17:36 GMT
Momenta receives OK for generic version of Lovenox
(AP)
AP - Biotechnology company Momenta Pharmaceuticals Inc. says the U.S. Food and Drug Administration has approved its generic version of the Sanofi-Aventis SA injected blood thinner Lovenox.
Pubished :Fri, 23 Jul 2010 20:54:04 GMT
AP - Biotechnology company Momenta Pharmaceuticals Inc. says the U.S. Food and Drug Administration has approved its generic version of the Sanofi-Aventis SA injected blood thinner Lovenox.
Pubished :Fri, 23 Jul 2010 20:54:04 GMT
FTC pushed Watson subpoena, denies info disclosure
(AP)
AP - The Federal Trade Commission has accused Watson Pharmaceuticals Inc. of delaying an investigation into a potential "pay-for-delay" deal on a generic sleep disorder drug.
Pubished :Fri, 23 Jul 2010 18:59:06 GMT
AP - The Federal Trade Commission has accused Watson Pharmaceuticals Inc. of delaying an investigation into a potential "pay-for-delay" deal on a generic sleep disorder drug.
Pubished :Fri, 23 Jul 2010 18:59:06 GMT
Report: Sanofi-Aventis, Genzyme talk acquisition
(AP)
AP - Shares of Genzyme Corp. soared Friday after a report was published that French pharmaceutical company Sanofi-Aventis is interested in the biotechnology drugmaker.
Pubished :Fri, 23 Jul 2010 18:23:41 GMT
AP - Shares of Genzyme Corp. soared Friday after a report was published that French pharmaceutical company Sanofi-Aventis is interested in the biotechnology drugmaker.
Pubished :Fri, 23 Jul 2010 18:23:41 GMT
Summary Box: Drugmakers post higher Q2 results
(AP)
AP - HEALTHY SIGNS: Three of the Top 20 drugmakers — Bristol-Myers Squibb Co., Roche Holding AG and Eli Lilly and Co. — all post better second-quarter profit as their sales increase.
Pubished :Thu, 22 Jul 2010 21:49:10 GMT
AP - HEALTHY SIGNS: Three of the Top 20 drugmakers — Bristol-Myers Squibb Co., Roche Holding AG and Eli Lilly and Co. — all post better second-quarter profit as their sales increase.
Pubished :Thu, 22 Jul 2010 21:49:10 GMT
Q2 sales, profit improve for 3 major drugmakers
(AP)
AP - Rising product sales helped three big drugmakers — Bristol-Myers Squibb Co., Roche Holding AG and Eli Lilly and Co. — post better second-quarter results on Thursday.
Pubished :Thu, 22 Jul 2010 21:28:23 GMT
AP - Rising product sales helped three big drugmakers — Bristol-Myers Squibb Co., Roche Holding AG and Eli Lilly and Co. — post better second-quarter results on Thursday.
Pubished :Thu, 22 Jul 2010 21:28:23 GMT
Eli Lilly 2Q sales for key drugs at a glance
(AP)
AP - Strong sales for several of Eli Lilly and Co.'s top drugs helped boost the Indianapolis company's second-quarter revenue by 9 percent.
Pubished :Thu, 22 Jul 2010 16:52:19 GMT
AP - Strong sales for several of Eli Lilly and Co.'s top drugs helped boost the Indianapolis company's second-quarter revenue by 9 percent.
Pubished :Thu, 22 Jul 2010 16:52:19 GMT
Medco 2Q profit rises, but stock hits 52-week low
(AP)
AP - Pharmacy benefits manager Medco Health Solutions Inc. said Thursday its profit rose 14 percent in the second quarter, but its shares sank as investors were concerned about how much money the company is making for each prescription it fills.
Pubished :Thu, 22 Jul 2010 16:49:44 GMT
AP - Pharmacy benefits manager Medco Health Solutions Inc. said Thursday its profit rose 14 percent in the second quarter, but its shares sank as investors were concerned about how much money the company is making for each prescription it fills.
Pubished :Thu, 22 Jul 2010 16:49:44 GMT
Medco Health Solutions 2Q profit at a glance
(AP)
AP - Medco Health Solutions Inc., the largest pharmacy benefits manager in the U.S., said Thursday its profit rose 14 percent in the second quarter as sales grew 10 percent. Here's a look at key quarterly metrics.
Pubished :Thu, 22 Jul 2010 16:43:59 GMT
AP - Medco Health Solutions Inc., the largest pharmacy benefits manager in the U.S., said Thursday its profit rose 14 percent in the second quarter as sales grew 10 percent. Here's a look at key quarterly metrics.
Pubished :Thu, 22 Jul 2010 16:43:59 GMT
Summary Box: Key drugs boost Lilly 2Q performance
(AP)
AP - SECOND-QUARTER NUMBERS: Indianapolis drugmaker Eli Lilly and Co. earned $1.35 billion, or $1.22 per share. That's up from $1.16 billion, or $1.06 per share, in the same period last year. Revenue rose 9 percent to $5.75 billion.
Pubished :Thu, 22 Jul 2010 16:23:12 GMT
AP - SECOND-QUARTER NUMBERS: Indianapolis drugmaker Eli Lilly and Co. earned $1.35 billion, or $1.22 per share. That's up from $1.16 billion, or $1.06 per share, in the same period last year. Revenue rose 9 percent to $5.75 billion.
Pubished :Thu, 22 Jul 2010 16:23:12 GMT
Eli Lilly 2Q profit jumps 16 pct on top drug sales
(AP)
AP - Eli Lilly and Co. said Thursday its second-quarter net income soared 16 percent, boosted partially by revenue growth from key drugs that face patent expirations in the coming years.
Pubished :Thu, 22 Jul 2010 15:16:19 GMT
AP - Eli Lilly and Co. said Thursday its second-quarter net income soared 16 percent, boosted partially by revenue growth from key drugs that face patent expirations in the coming years.
Pubished :Thu, 22 Jul 2010 15:16:19 GMT
Medco 2Q profit rises 14 percent on new business
(AP)
AP - Pharmacy benefits manager Medco Health Solutions Inc. said Thursday new clients and higher drug prices helped lift its net income 14 percent in the second quarter.
Pubished :Thu, 22 Jul 2010 14:09:10 GMT
AP - Pharmacy benefits manager Medco Health Solutions Inc. said Thursday new clients and higher drug prices helped lift its net income 14 percent in the second quarter.
Pubished :Thu, 22 Jul 2010 14:09:10 GMT
Roche half-year profit rises 37 percent to $5.3B
(AP)
AP - Pharmaceuticals maker Roche Holding AG on Thursday posted a 37 percent rise in six-month net profit on strong drug sales and lower costs related to its takeover of U.S.-based Genentech.
Pubished :Thu, 22 Jul 2010 10:35:26 GMT
AP - Pharmaceuticals maker Roche Holding AG on Thursday posted a 37 percent rise in six-month net profit on strong drug sales and lower costs related to its takeover of U.S.-based Genentech.
Pubished :Thu, 22 Jul 2010 10:35:26 GMT
Roche earnings sharply up
(AFP)
AFP - Swiss pharmaceutical giant Roche said Thursday its first half net income rose 37 percent compared to a year ago, thanks to lower than expected costs incurred in its buyout of US biotechnology unit Genentech.
Pubished :Thu, 22 Jul 2010 06:31:01 GMT
AFP - Swiss pharmaceutical giant Roche said Thursday its first half net income rose 37 percent compared to a year ago, thanks to lower than expected costs incurred in its buyout of US biotechnology unit Genentech.
Pubished :Thu, 22 Jul 2010 06:31:01 GMT
On The Call: Abbott CFO discusses higher costs
(AP)
AP - Abbott Laboratories' administrative expenses increased nearly 30 percent in the second quarter, the drug and medical device maker said Wednesday. The company's Chief Financial Officer Tom Freyman explained that the increase was due in part to the integration of Solvay Pharmaceuticals, which Abbott acquired last year.
Pubished :Wed, 21 Jul 2010 18:39:16 GMT
AP - Abbott Laboratories' administrative expenses increased nearly 30 percent in the second quarter, the drug and medical device maker said Wednesday. The company's Chief Financial Officer Tom Freyman explained that the increase was due in part to the integration of Solvay Pharmaceuticals, which Abbott acquired last year.
Pubished :Wed, 21 Jul 2010 18:39:16 GMT
GlaxoSmithKline reports Q2 loss on legal costs
(AP)
AP - GlaxoSmithKline, the world's second-largest pharmaceutical company by revenue, on Wednesday reported a loss of 304 million pounds ($464 million) for the second quarter as the company absorbed a hit of 1.57 billion pounds ($2.4 billion) for settling lawsuits.
Pubished :Wed, 21 Jul 2010 11:50:36 GMT
AP - GlaxoSmithKline, the world's second-largest pharmaceutical company by revenue, on Wednesday reported a loss of 304 million pounds ($464 million) for the second quarter as the company absorbed a hit of 1.57 billion pounds ($2.4 billion) for settling lawsuits.
Pubished :Wed, 21 Jul 2010 11:50:36 GMT
U.S. panel rejects Roche's Avastin for breast cancer
(Reuters)
Reuters - A U.S. advisory panel dealt a blow to Roche Holding AG's multibillion-dollar cancer drug Avastin on Tuesday, urging U.S. officials to revoke the medicine's approval for breast cancer.
Pubished :Tue, 20 Jul 2010 20:51:48 GMT
Reuters - A U.S. advisory panel dealt a blow to Roche Holding AG's multibillion-dollar cancer drug Avastin on Tuesday, urging U.S. officials to revoke the medicine's approval for breast cancer.
Pubished :Tue, 20 Jul 2010 20:51:48 GMT
Teva pays Fla. $27 mil in settlement
(AP)
AP - Teva Pharmaceuticals and its affiliates will pay Florida $27 million for allegedly inflating medication prices costing Medicaid millions of dollars in overpayments.
Pubished :Tue, 20 Jul 2010 15:29:43 GMT
AP - Teva Pharmaceuticals and its affiliates will pay Florida $27 million for allegedly inflating medication prices costing Medicaid millions of dollars in overpayments.
Pubished :Tue, 20 Jul 2010 15:29:43 GMT
FDA panel reconsiders Roche's breast cancer drug
(AP)
AP - Federal health advisers will vote Tuesday on whether to withdraw regulatory approval of the Roche drug Avastin for breast cancer treatment after the drug showed disappointing results in recent studies.
Pubished :Tue, 20 Jul 2010 14:18:22 GMT
AP - Federal health advisers will vote Tuesday on whether to withdraw regulatory approval of the Roche drug Avastin for breast cancer treatment after the drug showed disappointing results in recent studies.
Pubished :Tue, 20 Jul 2010 14:18:22 GMT
© -2008 DataSoftSystem.com